本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BioLife Solutions Inc.

28.90
+0.24000.84%
成交量:18.94萬
成交額:553.06萬
市值:13.84億
市盈率:-239.70
高:29.57
開:28.99
低:28.63
收:28.66
52周最高:29.57
52周最低:19.10
股本:4,790.53萬
流通股本:3,890.77萬
量比:0.83
換手率:0.49%
股息:- -
股息率:- -
每股收益(TTM):-0.1206
每股收益(LYR):-0.4381
淨資產收益率:-5.66%
總資產收益率:-0.80%
市淨率:3.99
市盈率(LYR):-65.96

資料載入中...

2025/10/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/21

重要事件披露

Form 8-K - Current report
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/08

重要事件披露

Form 8-K - Current report
2025/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/09

重要事件披露

Form 8-K - Current report
2025/04/08

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/03/24

重要事件披露

Form 8-K - Current report
2025/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]